|
|
Roche Case Study: Shaping the COVID-19 Diagnostic Testing Landscape
Content Declaration
Keep for 3 Years Language (In English)
English
|
|
|
These presentations provide a general overview of high sensitivity troponin to assess patients suspected of having an acute coronary event.
Content Declaration
Keep for 3 Years Language (In English)
english
|
|
|
These presentations provide a general overview of high sensitivity troponin to assess patients suspected of having an acute coronary event.
Content Declaration
Keep for 3 Years Language (In English)
english
|
|
|
These presentations provide a general overview of high sensitivity troponin to assess patients suspected of having an acute coronary event.
Content Declaration
Keep for 3 Years Language (In English)
english
|
|
|
These presentations provide a general overview of high sensitivity troponin to assess patients suspected of having an acute coronary event.
Content Declaration
Keep for 3 Years Language (In English)
english
|
|
|
These presentations provide a general overview of high sensitivity troponin to assess patients suspected of having an acute coronary event.
Content Declaration
Keep for 3 Years Language (In English)
english
|
|
|
These presentations provide a general overview of high sensitivity troponin to assess patients suspected of having an acute coronary event.
Content Declaration
Keep for 3 Years Language (In English)
english
|
|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a guided digital review of non-small cell lung carcinoma (NSCLC) specimens stained with the Ventana PD-L1 (SP263) Assay. This is…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
english
|
|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides instruction on evaluating the Ventana PD-L1 (SP263) assay in non-small cell lung carcinoma (NSCLC) cases. This is part 2 of a 3…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
english
|
|
|
Dr. Dorothy Hayden, a pathologist with Roche Diagnostics, provides a brief overview of the Ventana PD-L1 (SP263) assay & staining in non-small cell lung carcinoma (NSCLC) specimens. Please note…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No Language (In English)
English
|
|
|
Dr. Lupe Manriquez from Roche Diagnostics MSA discusses SP263 immune cell scoring. This is part 3 of a 3 part series. Veeva TE-US-01059
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Lupe Manriquez from the Roche Medical and Scientific Affairs team discusses immune cell scoring utilizing the SP263 assay. This is part 2 of a 3 part series. Veeva TE-US-01057
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Lupe Manriquez from the Roche Medical and Scientific Affairs team discusses immune cell scoring utilizing the SP263 assay. This is part 1 of a 3 part series Veeva #TE-US-01058
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|
|
|
Dr. Beatrice Wegrzyniak from the Roche Diagnostics US Medical and Scientific Affairs team provides an overview of the new Ventana HER2 Dual ISH assay, comparison to the original assay and examples of…
Content Declaration
Keep for 3 Years COREMAP Content classification C4
No. Language (In English)
English
|